ArticleFree neuropathology2026
Atypical central neurocytoma with anaplastic histological features in the lateral ventricle of a 37-year-old man.
Article in Free neuropathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of atypical central neurocytoma with anaplastic histological features in the lateral ventricle of a previously healthy 37-year-old man. Histologically, the tumor exhibited anaplastic cell morphology, necrosis, increased mitotic activity, and vascular proliferation. The tumor had copy number alterations, but methylation profiling did not provide a match to any known methylation class, and mutation analyses were negative for pathogenic alterations. Atypical central neurocytoma is a challenging and rare diagnosis, and the World Health Organization (WHO) Classification of Tumors has not yet clarified diagnostic criteria for this putative entity. In a literature review, however, atypical central neurocytoma showed increased aggressiveness compared to conventional central neurocytoma, WHO grade 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.